International Business News - OSIP http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Friday, June 27, from AP Financial News: NEW YORK (AP)--Shares of SunOpta Inc., which sells personal care products and natural and organic foods, sank more than 22 percent Friday after the company said it is replacing its two top executives following an ongoing audit investigation. http://www.ibtimes.com/articles/20080627/movers-roundup-sunopta-opnext.htm Fri, 27 Jun 2008 14:40:35 EDT Shares of OSI Pharmaceuticals Inc. rose Friday after a Thomas Weisel Partners analysts initiated coverage of the biopharmaceutical company with an "Overweight" rating, citing accelerating sales of the cancer drug Tarceva. http://www.ibtimes.com/articles/20080627/osi-shares-rise-on-weisel-overweight-rating.htm Fri, 27 Jun 2008 12:09:40 EDT Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesday. http://www.ibtimes.com/articles/20080624/sector-snap-biotech-_-large-cap-or-small-cap.htm Tue, 24 Jun 2008 12:51:24 EDT Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June 3 in Chicago. http://www.ibtimes.com/articles/20080516/sector-wrap-celgene-genentech-in-asco-spotlight.htm Fri, 16 May 2008 16:04:04 EDT Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva. http://www.ibtimes.com/articles/20080507/osi-shares-rise-after-posting-1q-profit-on-cancer-drug-sales.htm Wed, 07 May 2008 16:56:27 EDT OSI Pharmaceuticals Inc. said Friday it expects to pay $500,000 to settle a class-action lawsuit related to its Tarceva lung-cancer drug. OSI's full preliminary settlement amount is $9 million, but its insurer is covering the remainder of the amount. Terms of the settlement are subject to court approval. http://www.ibtimes.com/articles/20080314/osi-to-pay-500k-to-settle-lawsuit.htm Fri, 14 Mar 2008 16:25:28 EDT Health care company Abbott Laboratories said Friday it will work with Genentech Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals Inc. to develop a gene test to potentially determine the benefit of a certain lung cancer treatment. http://www.ibtimes.com/articles/20080307/abbott-working-on-lung-cancer-test.htm Fri, 07 Mar 2008 09:56:45 EST Shares of OSI Pharmaceuticals Inc. spiked Monday after a Wachovia analyst upgraded the biotechnology company, saying the stock has been oversold on exaggerated concerns about competition for lung cancer drug Tarceva. http://www.ibtimes.com/articles/20080303/osi-pharma-shares-up-on-wachovia-upgrade.htm Mon, 03 Mar 2008 13:17:59 EST OSI Pharmaceuticals Inc., which specializes in diabetes and cancer research, said Thursday it swung to a fourth-quarter profit from a year-ago quarter which was weighed by a heavy charge. http://www.ibtimes.com/articles/20080221/osi-pharmaceuticals-swings-to-4q-profit.htm Thu, 21 Feb 2008 17:54:59 EST Biotechnology stocks could be among the bright spots in what is shaping up to be an economically weak 2008, as drug development programs and demand for new therapies support the shares, analysts said Monday. http://www.ibtimes.com/articles/20080204/sector-snap-biotechnology.htm Mon, 04 Feb 2008 14:58:13 EST Data from ongoing colon cancer therapy studies will soon show if several drugs already on the market are more effective at treating patients who have the K-ras gene, which is typically associated with cancer. http://www.ibtimes.com/articles/20080128/sector-snap-colon-cancer-drugs.htm Mon, 28 Jan 2008 14:01:29 EST Shares of contract research company Pharmaceutical Product Development Inc. jumped Friday after the company's development partner asked the Food and Drug Administration to approve a new diabetes drug, triggering a milestone payment. http://www.ibtimes.com/articles/20080104/ppd-shares-rise-on-expected-payment.htm Fri, 04 Jan 2008 19:07:52 EST Biotechnology company OSI Pharmaceuticals Inc. said Friday it is offering $175 million in unsecured senior notes and will use the proceeds to buy back common stock and a separate class of senior notes. http://www.ibtimes.com/articles/20080104/osi-offering-175-million-in-notes.htm Fri, 04 Jan 2008 07:31:14 EST Biotechnology company OSI Pharmaceuticals Inc. on Wednesday said it plans to offer $150 million in convertible senior notes due 2038, partly to fund repurchases of shares and notes. http://www.ibtimes.com/articles/20080102/osi-to-offer-150m-in-convertible-notes.htm Wed, 02 Jan 2008 16:47:00 EST Shares of ImClone Systems Inc. closed out 2007 at the top of the biotechnology heap while rivals Amgen Inc. and Genentech Inc. counted themselves among the sector's biggest losers. http://www.ibtimes.com/articles/20071231/imclone-posts-biggest-2007-biotech-gain.htm Mon, 31 Dec 2007 13:56:59 EST Among the stock activity stories for Friday, Nov. 30, from AP Financial News: NEW YORK (AP) _ Shares of OSI Pharmaceuticals Inc. rose to a two-year high Friday after the company forecast a larger-than-expected 2008 profit on lower expenses and improving sales of cancer drug Tarceva. http://www.ibtimes.com/articles/20071130/movers-roundup-osi-pharma-enernoc.htm Fri, 30 Nov 2007 18:40:19 EST